Marluce Bibbo, MD, ScD

Marluce Bibbo, MD, ScD

Contact Dr. Bibbo

132 South 10th Street
Main Building Suite 260
Philadelphia, PA 19107

(215) 955-1197
(215) 955-2426 fax

Most Recent Peer-reviewed Publications

  1. Review of Cytology Practice at Thomas Jefferson University Hospital before and after High-Risk Human Papillomavirus Testing
  2. Diagnostic Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Porta Hepatis Lesions: A Retrospective Study
  3. Arginase-1 and HepPar-1 expression in fine-needle aspiration specimens of primary lungadenocarcinoma
  4. Cytopathology and management of ureteroscopic biopsy samples
  5. Non-neoplastic findings
  6. Overview of nongynecological samples prepared with liquid-based cytology medium
  7. Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions
  8. Ureteroscopic biopsy of upper tract urothelial carcinoma: Comparison of basket and forceps
  9. Thyroglobulin wash testing in the surveillance of patients with thyroid carcinoma: Proposal for a reflex test
  10. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome)
  11. The potential value of phosphohistone-H3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens
  12. Farewell message
  13. Farewell message
  14. Lung carcinoma in the era of personalized medicine: The role of cytology
  15. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
  16. Molecular analysis of centrifugation supernatant fluid from pancreaticobiliary duct samples can improve cancer detection
  17. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts
  18. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma
  19. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
  20. Thyroid FNA: Challenges and opportunities